The Latin America, Middle East and Africa Pharmaceutical Gelatin Market should witness market growth of 8.4 % CAGR during the forecast period (2022-2028).
Presently, natural origin-based safe materials are in high demand across the world. Thus, the requirement for a boost in advancements for patient safety is rising. Gelatin fulfills those demands. Gelatin is a naturally occurring protein that is obtained from animal collagen. It is non-allergenic. Also, it has been Generally Recognized as Safe (GARS) to use by FDA.
Gelatin has exceptional physical and chemical properties. In the manufacturing process of gelatin, the pharmaceutical industry is required to stick to the strict national and international pharmaceutical processing regulations. In medical innovation, the gelatin will continue to remain an essential part. Developments and exploration, particularly in the domain of regenerative medicine, where experiments on cell growth and repairing of body organs are being experimented, are still going on, holding a huge number of opportunities for the future.
Pig skin is the commonly used raw material in making gelatin due to its high collagen content. The product obtained from pig skin is common acts as a thickener, stabilizer, texturizer, and binder and also used in producing capsules. The porcine gelatin segment is in high demand by the food & beverage industry that uses porcine gelatin for making nutritional and sports products. Usage of bovine hide-based products will also surge in the upcoming years due to the significant amount of protein content in them and also their quality to absorb water easily.
Under the Tanzanian government’s Vision 2030, they plan to invest around $65 billion to develop the country’s healthcare infrastructure. Furthermore, to promote preventive and integrated care and enhance the accessibility to health services, the Ministry of Healthcare plans to initiate a health cluster across Tanzania. Hence, the increasing healthcare funding & infrastructure, the demand for gelatin-based medications will also surge, expanding the market for pharmaceutical gelatin in the LAMEA region.
The Brazil market dominated the LAMEA Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $31.3 million by 2028. The Argentina market is showcasing a CAGR of 9% during (2022-2028). Additionally, The Egypt market would register a CAGR of 7.5% during (2022-2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into Brazil, Argentina, Egypt, Tanzania, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Presently, natural origin-based safe materials are in high demand across the world. Thus, the requirement for a boost in advancements for patient safety is rising. Gelatin fulfills those demands. Gelatin is a naturally occurring protein that is obtained from animal collagen. It is non-allergenic. Also, it has been Generally Recognized as Safe (GARS) to use by FDA.
Gelatin has exceptional physical and chemical properties. In the manufacturing process of gelatin, the pharmaceutical industry is required to stick to the strict national and international pharmaceutical processing regulations. In medical innovation, the gelatin will continue to remain an essential part. Developments and exploration, particularly in the domain of regenerative medicine, where experiments on cell growth and repairing of body organs are being experimented, are still going on, holding a huge number of opportunities for the future.
Pig skin is the commonly used raw material in making gelatin due to its high collagen content. The product obtained from pig skin is common acts as a thickener, stabilizer, texturizer, and binder and also used in producing capsules. The porcine gelatin segment is in high demand by the food & beverage industry that uses porcine gelatin for making nutritional and sports products. Usage of bovine hide-based products will also surge in the upcoming years due to the significant amount of protein content in them and also their quality to absorb water easily.
Under the Tanzanian government’s Vision 2030, they plan to invest around $65 billion to develop the country’s healthcare infrastructure. Furthermore, to promote preventive and integrated care and enhance the accessibility to health services, the Ministry of Healthcare plans to initiate a health cluster across Tanzania. Hence, the increasing healthcare funding & infrastructure, the demand for gelatin-based medications will also surge, expanding the market for pharmaceutical gelatin in the LAMEA region.
The Brazil market dominated the LAMEA Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $31.3 million by 2028. The Argentina market is showcasing a CAGR of 9% during (2022-2028). Additionally, The Egypt market would register a CAGR of 7.5% during (2022-2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into Brazil, Argentina, Egypt, Tanzania, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Scope of the Study
By Type
- Type B
- Type A
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Function
- Stabilizing Agent
- Thickening Agent
- Gelling Agent & Others
By Application
- Hard Capsules
- Softgel Capsules
- Tablets
- Absorbable Hemostats
- Others
By Country
- Brazil
- Argentina
- Egypt
- Tanzania
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Pharmaceutical Gelatin Market, by Type
1.4.2 LAMEA Pharmaceutical Gelatin Market, by Source
1.4.3 LAMEA Pharmaceutical Gelatin Market, by Function
1.4.4 LAMEA Pharmaceutical Gelatin Market, by Application
1.4.5 LAMEA Pharmaceutical Gelatin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Pharmaceutical Gelatin Market
Chapter 4. LAMEA Pharmaceutical Gelatin Market by Type
4.1 LAMEA Type B Market by Country
4.2 LAMEA Type A Market by Country
Chapter 5. LAMEA Pharmaceutical Gelatin Market by Source
5.1 LAMEA Porcine Market by Country
5.2 LAMEA Bovine Skin Market by Country
5.3 LAMEA Bovine Bone Market by Country
5.4 LAMEA Marine Market by Country
5.5 LAMEA Poultry Market by Country
Chapter 6. LAMEA Pharmaceutical Gelatin Market by Function
6.1 LAMEA Stabilizing Agent Market by Country
6.2 LAMEA Thickening Agent Market by Country
6.3 LAMEA Gelling Agent & Others Market by Country
Chapter 7. LAMEA Pharmaceutical Gelatin Market by Application
7.1 LAMEA Hard Capsules Market by Country
7.2 LAMEA Softgel Capsules Market by Country
7.3 LAMEA Tablets Market by Country
7.4 LAMEA Absorbable Hemostats Market by Country
7.5 LAMEA Others Market by Country
Chapter 8. LAMEA Pharmaceutical Gelatin Market by Country
8.1 Brazil Pharmaceutical Gelatin Market
8.1.1 Brazil Pharmaceutical Gelatin Market by Type
8.1.2 Brazil Pharmaceutical Gelatin Market by Source
8.1.3 Brazil Pharmaceutical Gelatin Market by Function
8.1.4 Brazil Pharmaceutical Gelatin Market by Application
8.2 Argentina Pharmaceutical Gelatin Market
8.2.1 Argentina Pharmaceutical Gelatin Market by Type
8.2.2 Argentina Pharmaceutical Gelatin Market by Source
8.2.3 Argentina Pharmaceutical Gelatin Market by Function
8.2.4 Argentina Pharmaceutical Gelatin Market by Application
8.3 Egypt Pharmaceutical Gelatin Market
8.3.1 Egypt Pharmaceutical Gelatin Market by Type
8.3.2 Egypt Pharmaceutical Gelatin Market by Source
8.3.3 Egypt Pharmaceutical Gelatin Market by Function
8.3.4 Egypt Pharmaceutical Gelatin Market by Application
8.4 Tanzania Pharmaceutical Gelatin Market
8.4.1 Tanzania Pharmaceutical Gelatin Market by Type
8.4.2 Tanzania Pharmaceutical Gelatin Market by Source
8.4.3 Tanzania Pharmaceutical Gelatin Market by Function
8.4.4 Tanzania Pharmaceutical Gelatin Market by Application
8.5 South Africa Pharmaceutical Gelatin Market
8.5.1 South Africa Pharmaceutical Gelatin Market by Type
8.5.2 South Africa Pharmaceutical Gelatin Market by Source
8.5.3 South Africa Pharmaceutical Gelatin Market by Function
8.5.4 South Africa Pharmaceutical Gelatin Market by Application
8.6 Nigeria Pharmaceutical Gelatin Market
8.6.1 Nigeria Pharmaceutical Gelatin Market by Type
8.6.2 Nigeria Pharmaceutical Gelatin Market by Source
8.6.3 Nigeria Pharmaceutical Gelatin Market by Function
8.6.4 Nigeria Pharmaceutical Gelatin Market by Application
8.7 Rest of LAMEA Pharmaceutical Gelatin Market
8.7.1 Rest of LAMEA Pharmaceutical Gelatin Market by Type
8.7.2 Rest of LAMEA Pharmaceutical Gelatin Market by Source
8.7.3 Rest of LAMEA Pharmaceutical Gelatin Market by Function
8.7.4 Rest of LAMEA Pharmaceutical Gelatin Market by Application
Chapter 9. Company Profiles
9.1 Nitta Gelatin, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Sales Category and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Product Launches and Product Expansions:
9.2 Tessenderlo Group nv
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.3 Lonza Group Ltd. (Capsugel)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:’
9.4 Catalent, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Darling Ingredients, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 GELITA AG
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.6.2.2 Acquisition and Mergers:
9.7 Roxlor Group
9.7.1 Company Overview
9.8 Norland Products, Inc.
9.8.1 Company Overview
9.9 SAS Gelatines Weishardt
9.9.1 Company Overview
Companies Mentioned
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Methodology
LOADING...
